#Interventional Pulmonology Market Size

[amrutatbrc1]

Pulmonology Devices Market 2024 : Industry Analysis, Trends, Segmentation, Regional Overview And Forecast 2033

Overview and Scope Pulmonology devices are medical instruments and equipment used in the diagnosis, treatment, and management of respiratory system conditions and diseases. These devices play a crucial role in assessing lung function, monitoring respiratory health, providing therapeutic interventions, and supporting patients with respiratory disorders.

Sizing and Forecast The pulmonary devices market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising incidence of chronic respiratory diseases, growing shift towards preventive healthcare, increase in adoption of pulmonology devices, surge in incidence of diseases requiring endoscopic ultrasound procedures, increase in geriatric population.

The pulmonary devices market size is expected to see rapid growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rise in prevalence of respiratory diseases, rising air pollution levels, growth in home healthcare, growing awareness and early diagnosis, expansion of healthcare infrastructure. Major trends in the forecast period include integration of artificial intelligence, growth of telemedicine and remote monitoring, advancements in portable and wearable devices, use of robotic technology in less-invasive diagnostic procedures, increase in home care services.

Order your report now for swift delivery, visit the link: https://www.thebusinessresearchcompany.com/report/pulmonology-devices-global-market-report

Segmentation & Regional Insights The pulmonology devices market covered in this report is segmented –

1) By Product Type: Endobronchial Ultrasound (EBUS) Needles, Pulmonary Biopsy Devices, Airway Stents, Single-Use Bronchoscopes, Other Product Types 2) By Indication: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Tracheal And Bronchial Stenosis, Foreign Body Extraction, Other Indications 3) By End-User: Pulmonology Clinics, Hospitals, Ambulatory Surgical Centers

North America was the largest region in the pulmonology devices market in 2023. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=16772&type=smp

Major Driver Impacting Market Growth The rise in the prevalence of respiratory diseases is expected to propel the growth of the pulmonology devices market going forward. Respiratory diseases are a group of medical conditions that affect the organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The cases of respiratory diseases are occurring due to rising air pollution, smoking, and occupational hazards. Pulmonology devices aid in respiratory disease management by enabling accurate diagnosis, continuous monitoring, and effective treatment through tools like spirometers, inhalers, pulse oximeters, and ventilators, ultimately improving patient outcomes and quality of life. For instance, according to the Scottish Public Health Observatory, a Scotland-based public health agency, COPD rates began rising in 2021-22 as the effects of COVID-19 lessened. The rate among males rose from 83.2 to 97.6 cases per 100,000, while it increased from 72.6 to 97.3 among females. Therefore, the rise in the prevalence of respiratory diseases is driving the growth of the pulmonology devices market.

Key Industry Players Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX

The pulmonology devices market report table of contents includes:

1. Executive Summary

2. Pulmonology Devices Market Characteristics

3. Pulmonology Devices Market Trends And Strategies

4. Pulmonology Devices Market - Macro Economic Scenario

5. Global Pulmonology Devices Market Size and Growth ..........

32. Global Pulmonology Devices Market Competitive Benchmarking

33. Global Pulmonology Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pulmonology Devices Market

35. Pulmonology Devices Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[medicaldevicesmarket]

Harmony in Healing: Navigating the ENT Devices Market Landscape

The ENT Devices Market, encompassing a spectrum of cutting-edge technologies, plays a crucial role in the diagnosis and treatment of Ear, Nose, and Throat (ENT) disorders. This exploration delves into key segments, including Endoscopy Devices, ENT Devices, ENT Disorder Treatment, and the intersection with Bronchoscopy Devices, to provide a comprehensive understanding of this dynamic healthcare sector.

1. Endoscopy Devices Market: Illuminating Diagnostic Precision:-

Within the broader ENT Devices Market, Endoscopy Devices emerge as instrumental tools for precise diagnosis. These devices, including flexible and rigid endoscopes, offer clinicians a direct view of the nasal and throat passages, enabling accurate assessments and targeted treatments. Estimated at US$10.4 billion in 2023, this segment encompasses bronchoscopes, laryngoscopes, and otoscopes, allowing for minimally invasive visualization and diagnosis of ENT conditions.

2. ENT Devices Market: Orchestrating Comprehensive Care:-

The global ENT Devices Market boasts a hefty valuation of US$23.5 billion in 2023, projected to reach a staggering US$38.9 billion by 2028. This translates to a CAGR of 7.4%, a testament to the growing demand for advanced solutions to address a diverse range of ENT issues. Several key factors fuel this growth:

Rising Prevalence of ENT Disorders: Allergies, sinusitis, hearing loss, and throat infections are on the rise due to factors like pollution, aging populations, and increased awareness.

Technological Advancements: Minimally invasive endoscopic tools, image-guided surgery systems, and sophisticated diagnostic equipment are revolutionizing ENT care.

Focus on Early Diagnosis and Personalized Treatments: Early detection and targeted treatment plans improve outcomes and reduce healthcare costs.

Growing Demand for Aesthetics: Procedures like rhinoplasty and otoplasty are gaining traction, further propelling market growth.

3. ENT Disorder Treatment Market: Precision in Therapeutic Solutions:-

The ENT Disorder Treatment Market is a dedicated segment within ENT healthcare, focusing on therapeutic interventions for a range of disorders. From pharmaceuticals and surgical procedures to innovative non-invasive treatments, this market segment addresses the diverse needs of patients with ENT conditions. The Global ENT Treatment Market accounted for USD 21,061 million in 2021. It is anticipated to reach USD 33,520 million by 2030 with a CAGR of 5.2% from 2022 to 2030. The market is driven by the rising incidence of ENT disorders such as hearing loss, sinusitis, and sleep apnea.

4. ENT and Bronchoscopy Devices Market: Bridging Respiratory and ENT Care:-

The intersection of ENT and Bronchoscopy Devices creates a synergy between respiratory and ENT healthcare. Bronchoscopy devices, traditionally associated with pulmonary care, are increasingly utilized to address conditions affecting the upper airways, reinforcing the collaborative nature of medical specialties. Bronchoscopy Market size was valued at USD 2.8 billion in 2022 and is estimated to account for USD 6 billion by 2032. Bronchoscopy is the most common interventional pulmonology technique performed using a bronchoscope. It can be carried out using either single-use or reusable bronchoscopes.

Market Dynamics and Future Trends:-

The ENT Devices Market is characterized by a dynamic interplay of technological innovation, patient-centric care, and interdisciplinary collaborations. Future trends may include the integration of artificial intelligence for diagnostic support, the development of minimally invasive treatment options, and the expansion of telehealth solutions for remote patient monitoring.

Challenges and Opportunities:-

Challenges within the ENT Devices Industry encompass the need for continuous technological upgrades, ensuring accessibility to advanced devices in diverse healthcare settings, and addressing regulatory considerations. Opportunities lie in fostering collaborations between ENT specialists and pulmonologists, expanding the market reach in emerging economies, and refining patient-centric solutions.

Conclusion:-

In conclusion, the ENT Devices Market emerges as a beacon of innovation and precision in healthcare, addressing the intricate and interconnected aspects of ear, nose, and throat disorders. From diagnostic clarity with Endoscopy Devices to therapeutic versatility in the ENT Disorder Treatment Market, this sector plays a vital role in enhancing patient outcomes and quality of life. As technological advancements continue to shape the landscape, the ENT Devices Market remains at the forefront of providing comprehensive and compassionate care for individuals experiencing ENT health challenges.

[nidarsanafwr]

Global Interventional Pulmonology Market Size, Overview, Key Players and Forecast 2031

[newmarketplace]

What Would Be The Scope Of The Interventional Pulmonology Market In The Next 10 Years?

Interventional pulmonology is an area of pulmonary medicine that deals specifically with minimally invasive endoscopic and percutaneous procedures for the diagnosis and treatment of neoplastic as well as non-neoplastic diseases of the airways, lungs, and pleura. Rise in the number of COPD cases across the world is expected to boost demand over the coming years. Need for faster recovery time and reduced pain during procedures and surgeries for respiratory disorders has strengthened the market. Leading manufacturers of interventional pulmonology devices are focusing on geographical expansion to increase revenue and add new repair and service centers in emerging countries through the acquisition of local players.

Various awareness programs have been initiated by healthcare providers and health organizations/societies such as environmental programs, medication maintenance programs, and online education programs for public and healthcare professionals across the globe to control asthma, COPD, and other respiratory diseases. Major companies such as Boston Scientific Corporation, Olympus Corporation, and FUJIFILM Corporation, besides others, are focused on spreading awareness regarding respiratory diseases.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12544

Companies covered in Interventional Pulmonology Market Report

Medtronic Plc

Boston Scientific Corporation

Olympus Corporation

FUJIFILM Corporation

Becton, Dickinson and Company

Smiths Group Plc

Cook Medical

Vygon

Clarus Medical LLC

Huger Medical Instrument Co. Ltd

Taewoong Medical Co. Ltd.

Shanghai AoHua Photoelectricity Endoscope Co., Ltd

Karl Storz

Richard Wolf Corporation

PENTAX Medical

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12544

As per Persistence Market Research analysis, the global interventional pulmonology market is expected to exhibit a CAGR of more than 4% over the forecast period (2021 – 2031).

Key Takeaways from Study

IP diagnostic devices are expected to hold maximum revenue share under products.

Lung cancer is projected to be the dominant segment among indications, in terms of revenue. The segment accounted for 26.6% share in 2020.

The U.S., followed by Europe, is expected to hold substantial revenue share in the global interventional pulmonology market.

Emerging economies such as China, India, Brazil, Mexico, and South Africa have a large COPD patient pool, and rising disposable income of patients with increased healthcare expenditure would encourage interventional pulmonology device manufacturers to enter these markets.

The interventional pulmonology space faced adverse effects due to the COVID-19 crisis as a result of supply chain disruptions and economic impact of the pandemic on small- and medium-sized enterprises.

Hospitals and diagnostic centers to account for bulk of the market share (around ¾).

“Rising global prevalence of various respiratory diseases has increased demand for effective diagnosis and treatment in order to better manage the progression rate of these diseases,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12544

Acquisitions of Small & Medium Players – Imperative Strategy for Market Players

Given the consolidation in the market, bigger players are focusing on the acquisition of small and medium market players. This trend is being observed across North America and Europe. This is dominated by players with a strong regional distribution presence in terms of direct sales force and medical ventilator product manufacturing.

What else is in the report?

Persistence Market Research offers actionable insights and unique perspective on the interventional pulmonology market in its latest study, presenting historical demand assessment of 2016 – 2019 and projections for 2021–2031, based on product (Electromagnetic Navigation Bronchoscopy (ENB), IP Diagnostic Devices, IP therapeutic devices), indication (Asthma, Lung Cancer, COPD, Foreign Body Extraction, Tracheal and Bronchial Stenosis), and end user (Hospitals, Pulmonology Clinics, Ambulatory Surgical Centers, Diagnostic Centers), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research Address – 305 Broadway, 7th FloorNew York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – sales@persistencemarketresearch.com Website – https://www.persistencemarketresearch.com

[vijayanger12]

This explains why the market is estimated to register a striking CAGR of ~9% during the forecast period.

[unabashedcollectivepizza]

Interventional Pulmonology Market Global Share, Size, Trends Analysis, 2026

Global Interventional Pulmonology Market is expected to grow at a CAGR of 7.3% during the forecast period. Global Interventional Pulmonology Market is expected to reach US$ 750 Mn. by 2027.

Interventional Pulmonology Market Overview:

The Interventional Pulmonology Market's drivers, restraints, technical advancements, product developments, market opportunities, challenges, growth strategies, and market prospects, along with the forecast period, are briefly covered in the Global Interventional Pulmonology Market research report. The global Interventional Pulmonology market research report offers an in-depth analysis of the industry, including key figures like market size, market share, revenue growth, and CAGR for the forecast period (2021 to 2027).

Request for free sample:

https://www.maximizemarketresearch.com/request-sample/78478

Market Scope:

Maximize Market Research's analysis focus on the most essential regional market share data. At the same time, it emphasises the most crucial components of each regional market's growth trends. The study also offers a comprehensive geographic analysis of the industry, highlighting the sector's growth potential as well as market challenges in each of the world's major regions.

Based on the in-depth analysis, the report also provides essential information on important characteristics such as market share, size, and growth rate. Other aspects of the economic forecast, such as investment feasibility, demand and supply, import and export status, supply chain management, and growth projections, reveal a lot about the economy's prospects in the years ahead.

Get more Report Details:

https://www.maximizemarketresearch.com/market-report/global-interventional-pulmonology-market/78478/

Segmentation:

The growth of the interventional pulmonology market is being driven by the increased incidence of lung cancer and other chest-related medical problems. Several government and healthcare provider-led public awareness efforts about asthma, COPD, and other pulmonary disorders are propelling the market forward. Lung cancer is one of the top causes of death around the world. Lung cancer claimed the lives of about 3 million people in 2018, according to the World Health Organization (WHO).

Key Players:

• Boston Scientific Corporation • Olympus Corporation • FUJIFILM Corporation • Becton, Dickinson and Company • Smiths Group plc. • Cook Medical

Regional Analysis:

The global Interventional Pulmonology Market's growth trend is examined in depth throughout this report. It shows how the most major regional divides, such as North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, have global dominance.

COVID-19 Impact Analysis on Interventional Pulmonology Market:

Given the current state of uncertainty induced by COVID-19, the report is more important than before. In order to improve readiness, the paper explores dialogues to overcome past interruptions and anticipate future ones. In order to recover from such disruptive movements, businesses can use the frameworks to construct their strategic alignments. MMR analysts assist readers in deciphering a complex situation and adding resiliency to an uncertain situation.

In order to increase preparation, the paper explores dialogues to overcome past interruptions and anticipate future ones. In order to recover from such disruptive movements, businesses can use the frameworks to construct their strategic alignments. Maximize Market Research analysts also assist users in breaking down a complex circumstance and bringing resiliency to a situation, which is more uncertain.

Key Questions answered in the Interventional Pulmonology Market Report are:

What is the sales value, production value, consumption value, import and export of Interventional Pulmonology globally (North America, Europe, Asia-Pacific, South America, Middle East, and Africa)?

Who are the major players in the Interventional Pulmonology Industry on a worldwide scale? What is the state of their business (capacity, production, sales, pricing, cost, gross, and revenue)?

What are the market possibilities and dangers for Interventional Pulmonology providers in the global Interventional Pulmonology industry?

Which application, end-user, or product category might be looking for new growth opportunities? What is each type's and application's market share?

[mrunalnerkarblog]

Interventional pulmonology uses non-surgical, minimally invasive procedures for the diagnosis and treatment of lung cancer, thoracic cancer, tracheal cancer, and other diseases related to the respiratory system. It relies on endoscopic techniques, which involve inserting an instrument into the human body to view internal organs and tissues and to conduct additional procedures. Interventional pulmonary medicine is also used to treat related symptoms that may cause discomfort, such as shortness of breath, coughing, and chest pain.

[jayashreeblr-blog]

Latin America Active Pharmaceutical Ingredients Market is expected to reach USD 32.9 Billion by 2026 from USD 19.5 Billion in 2016 at a CAGR of 5.4% (Detailed analysis of the market CAGR is provided in the report).

 The active pharmaceutical ingredient or API component is responsible for producing the medicinal effects in any drug. The API is also known as active ingredients are form the most important constituent of any drug. The drug comprises two components specifically the API and the excipient. The API component is chemically active and forms the main medication. The excipient component is chemically inert and does not react with the API. The main function of the excipient is to cover the API and transfer it to the human body system. The quantity and type of API are decided by the manufacturers post considering the pre-notified standards. The API quantity may vary from one brand to another as patients have comparatively more knowledge about API than the excipient.

 Latin America Active Pharmaceutical Ingredients Market

Synthesis type, drug type, manufacturer type, therapeutic area, and geography are the various segments under the active pharmaceutical market in Latin America. The manufacturer type segment is demarcated into merchant and captive manufacturers. The merchant manufacturers monitored one of the fastest growth owing to rise in outsourcing of drug formulation by manufacturers. It reduces or eliminates the requirement of the heavy investment for a manufacturing process. Considering the synthesis type segment, it is biotech and synthetic that forms two major segments of the active pharmaceutical ingredients market. Growth in R&D activities for biosimilar drugs together with the change in focus of traditional manufacturers towards biological drugs are some major factors that have resulted in the higher growth of the biotech segment. Over-the-counter (OTC), generic and branded drugs are the three-drug types on the basis of which the market is segmented for active pharmaceutical ingredients. There is a rise in drug prices along with a higher spending over the healthcare related R&D activities in Latin America. These have together helped in propelling the demand for branded drugs in Latin America market for active pharmaceutical ingredients.

 Brazil is the fastest growing region as well as the largest in terms of offshore investments. Companies globally are coming to Latin America for manufacturing products at a cheaper labor cost. The infrastructural difficulties still loom at large in this region that is also expected to improve post government intervention. Overcoming the difficulties related to the healthcare sector coupled with more investments from pharmaceutical companies is expected to improve the growth of active pharmaceutical ingredients market in Latin America.

 Key Highlights:

 • Latin America Active Pharmaceutical Ingredients market size analysis and forecast

• Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Latin America Active Pharmaceutical Ingredients Market

• Active Pharmaceutical Ingredients market segmentation on the basis of synthesis type, drug type, manufacturer type, therapeutic area, and geography.

• Active Pharmaceutical Ingredients market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study

• Active Pharmaceutical Ingredients market analysis and forecast for major countries have been provided.

• Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies

• Competitive landscape of the key players operating in the Active Pharmaceutical Ingredients market including competitive developments, investments, and strategic expansion

 Years that have been considered for the study are as follows:

 • Base Year – 2016

• Estimated Year – 2017

• Forecast Period – 2017 to 2026

 For company profiles, 2016 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered.

 Research Methodology

 The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for Latin America Active Pharmaceutical Ingredients Market.

  Some of the key players of the Latin America Active Pharmaceutical Ingredients Market include:

 • Blanver EN

• Lupin

• Nortec Quimica

• Synthon

• Norkem

• Humco

• Romikin

• Chemo Argentina

• RovaFarm

• Merck

 Key Target Audience:

 • Healthcare companies

• Corporate healthcare entities

• Government agencies

• Market research and consulting firms

• Venture capitalists

• Technical Students

For more information visit:

https://www.maximizemarketresearch.com/market-report/latin-america-active-pharmaceutical-ingredients-market/2302/

Scope of the Report:

 The research report segments Latin America Active Pharmaceutical Ingredients market based on synthesis type, drug type, manufacturer type, therapeutic area and geography.

 Active Pharmaceutical Ingredients Market, By Synthesis Type

 • Biotech

• Monoclonal Antibodies

• Recombinant Proteins

• Vaccines

• Synthetic

 Active Pharmaceutical Ingredients Market, By Drug Type

• Branded Drugs

 • Generic Drugs

• Over-the-counter (OTC) Drugs

 Active Pharmaceutical Ingredients Market, By Manufacturer Type

 • Captive Manufacturers

• Merchant Manufacturers

 Active Pharmaceutical Ingredients Market, By Therapeutic Area

 • Cardiology

• Pulmonology

• Oncology

• Neurology

• Ophthalmology

• Orthopedics

• Others

 Active Pharmaceutical Ingredients Market, By Geography:

 • Latin America

• Brazil

• Chile

• Argentina

• Others

 Geographic Analysis

 • Breakdown of Brazil Active Pharmaceutical Ingredients Market

• Breakdown of Chile Active Pharmaceutical Ingredients Market

• Breakdown of Argentina Active Pharmaceutical Ingredients Market

• Breakdown of Others Active Pharmaceutical Ingredients Market

  This Report Is Submitted By Maximize Market Research

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

 About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

 Contact info:                                        

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Maharashtra 411051, India.

Contact:+919607065656

[oanda-pp]

Pink Himalayan Salt Is a Waste of Money

Sure it looks nice, but claims that it’s cleaner and more nutritious than regular salt are dubious at best.

Zoran Djekic / Stocksy

Right around January 1 the past few years, Google searches for “pink Himalayan salt” spike like your blood pressure after consuming a bucket of French fries. To become a better, healthier version of yourself, apparently, you absolutely must switch to using luscious pink-tinged salt crystals instead of those factory-refined white grains. Or so wellness experts and influencers might lead us to believe—and lots of us probably want to believe so we can feel less bad about craving salt.

While all trendy foods have hyperbole built into their marketing (looking at you, bone broth aka expensive meat tea) pink Himalayan salt might take the cake: Yes, it costs more, but it’s natural, unrefined salt with dozens of minerals and elements that’s extracted by hand from mines untouched by pollution! And it looks nice!

As Amanda Mull recently wrote in The Atlantic, we can attribute pink salt’s popularity to its pleasing appearance combined with trendy concepts of wellness in which “single foods or ingredients end up with a vague reputation for quasi-medicinality, often based on notions of their purity or naturalness.”

OK fine, but is pink salt healthier than regular table salt?

The wellness claims about pink salt range from dumb to dangerous. Dr. Axe says pink Himalayan salt is “cleaner” and more nutritious than regular salt. His site even swears it’s a natural sleep inducer. GOOP promises its $40 Pink Himalayan Salt Scrub will “detoxify” your skin. SoWell.com swears breathing pink salt-ified air will cure your asthma—and conveniently sells the inhaler pipe that will deliver your respiratory salvation. And finally, there’s this mumbo-jumbo over on HimalayanCrystalSalt.com about a 2007 study using an Optimized Wellness Analyzer to evaluate pink salt’s effect on “wellness” versus a placebo. Surprise: The pink salt group scored healthier when evaluated by the wellness analyzer. Less of a surprise: I couldn’t find the study on PubMed or Google Scholar, and the website doesn’t cite which peer-reviewed journal the study was published in.

If any of these claims are valid(ish), it’s that pink salt may have more minerals than purified white salt—but it’s a drop in the bucket. “Himalayan salt does contain trace amounts of minerals like potassium, magnesium, iron, and more, but the amounts are insignificant and afford no additional health benefits,” says Jeff McGrath, a clinical dietitian at Westchester Medical Center, the university hospital of New York Medical College. And as long as you’re eating a healthy, balanced diet, you’re probably not in need of these elements, McGrath says. (In case you’re wondering where the salt’s rosy hue comes from, it probably comes from “Iron oxide, AKA rust,” says Catherine Brennan, a Rhode Island-based registered dietitian. Yum.)

Speaking of its nutritional value, pink Himalayan salt usually doesn’t contain significant amounts of iodine, which is an essential nutrient, Brennan says. While iodine deficiencies are uncommon in the United States (thanks to salt with iodine added, aka iodized salt), it’s a real problem around the globe. “Iodine’s main function is as an important component of thyroid hormones,” Brennan says.“Persons deficient in iodine cannot make enough thyroid hormone, which can lead to hypothyroidism, or even enlargement of the thyroid—known as goiter."

And, “Ironically, Himalayan pink salt also contains barely detectable amounts of elements that would be harmful if isolated and consumed in large doses, such as arsenic and uranium,” McGrath says.

Claims that Himalayan salt is somehow more natural or pure than regular table salt are hard to verify—and may not really matter. “In the current food world, the term ‘natural’ means very little,” Brennan says. Yes, white salt is cleaned, heated, and treated with anti-caking agents, she explains, but sometimes a little bit of scrubbing can be a good thing. “Depending on the source, pink salt may contain some harmful trace minerals such as lead.”

If you want to keep buying pink Himalayan salt, that’s fine—just know that it’s not any better for you than boring, old white salt. And sorry not sorry: Pink Himalayan salt-laced potato chips, popcorn, and chocolate bars are not health foods.

But please, please, please don’t drink Himalayan salt mixed with a glass of water each morning the way some health and lifestyle bloggers and salt companiesurge you to. While that’s a great way to sell salt, “The American diet tends to provide significantly more sodium than is required,” McGrath says, adding that “excess sodium intake contributes to high blood pressure, which can eventually cause strokes and lead to heart and kidney failure.”

What about that stuff about pink salt helping you breathe better?

Don’t expect pink salt lamps or salt rooms to cure your asthma either. “In Eastern Europe and Russia, people have been descending into salt caves to treat respiratory diseases, but we don’t have very much rigorous data on it,” says Maureen George, an associate professor at Columbia University’s School of Nursing. “If the air contains microscopic salt crystals, that can cause a change in the mucus in the lungs and can cause coughing, which some find worsen their asthma, but some find it makes them feel better,” she says. Still, any results would be temporary.

There is one study, published in Pediatric Pulmonology in 2016, that found children’s asthma did improve directly after a “halotherapy” session, aka time spent in a salt room. However, George points out that the study only used children with asthma so moderate they didn’t need daily inhaler treatment, and that the results were measured only right after the session. “It’s a small signal that immediately after the artificial salt room therapy that kids in this trial had better quality of life scores and less airway twitchiness,” she says, but, “we don’t have any long-term, rigorously designed studies or large, randomized studies.”

Furthermore, to get the better-breathing benefits, you’d need the salt particles to be in the air—and a nightstand salt lamp definitely isn’t going to produce that result.

Still, if you want to go sit in a salt room to meditate, George isn’t going to stop you. “I’m a scientist, but I’m really into letting people do what works for them, and we know that mind-body interventions can be a powerful tool” she says. Just don’t stop using your asthma meds without consulting your physician.

Finally, the pink salt inhalers are likely useless for asthma treatment. “The device they’re using is not FDA-approved and looks like something that would only impact the upper respiratory tract. It’s what would land in your nose and mouth,” George explains. Getting medicine deep into your lungs—where it’s actually going to help you—is pretty tricky. “The tech in asthma inhalers is really complicated. It’s all about particle size and carriers.”

Anything else I need to know?

Most of these pink Himalayan salt remedies aren’t going to hurt you (minus the daily saltwater-chugging routine, that is not good). But overpaying for seasonings and snacks and shelling out $40 for a useless product smarts. And trust us, no matter what GOOP tells you, rubbing salt in the wound—even if it’s pink and (kinda) from the Himalayas—won’t help.

Oh yeah, and only kinda from the Himalayas. Banish those images of gorgeous pink salt mountain cliffs rising into the clouds in the world’s highest mountain range: Most pink Himalayan salt actually comes from a Pakistani government-owned mine that’s south of the famed mountains. The Khewra Salt Mine is now a tourist attraction, but its history is violent. During British colonial rule, the British forced locals to work in slave-like conditions in the mine. Even today, wages are low. Pakistani newspaper The Dawn reported in 2018 that a miner makes 350 Pakistani rupees, or about $2.50, for every ton of salt excavated. Think about that the next time you spend $5.99 for four ounces of the stuff on Amazon.

This article originally appeared on Tonic.

[chetanare]

Interventional Pulmonology Market: Global Industry Trends, Share, Size, Growth, Opportunity And Forecast 2020-2026

Interventional Pulmonology Market: Global Industry Trends, Share, Size, Growth, Opportunity And Forecast 2020-2026

The recent research report titled “Global Interventional Pulmonology Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)” has been added in the kandjmarketresearch.com database. This market report is a valuable source of insightful data for business strategists. It offers the industry overview with growth…

[nidarsanafwr]

Global Interventional Pulmonology Market Size, Overview, Key Players and Forecast 2031

[coolluminaryland-blog1]

Thoracic Drainage Devices Market to Become Worth US$ 916.2 Mn in 2025

The global thoracic drainage devices market was valued at US$ 555.8 Mn in 2016 and is expected to grow at a high CAGR of 6% from 2017 to 2025, to reach an estimated value of US$ 916.2 Mn in 2025 according to a new report published by Transparency Market Research (TMR) titled “Thoracic Drainage Devices Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025” the report suggests that  thoracic and pulmonological disorders are quite common and gradually increasing across the globe is driving the growth of thoracic drainage devices market in coming years (2017 to 2025).

The North America and Europe are projected to dominate the global market. The market is primarily driven by factors such as highly structured health care industry and availability of well-defined reimbursement policies from private and public health insurance firms boost the growth of the thoracic drainage devices market in the region. The market in Asia Pacific is projected to witness exponential growth rate with more than 12% during the forecast period 2017-2025. Asia Pacific is the fastest growing regions in the global thoracic drainage devices market in upcoming forecast period. The market in Asia Pacific is projected to witness exponential growth rate with more than 5.8% during the forecast period 2017-2025. The market for thoracic drainage devices market in Latin America is likely to grow at moderate growth rate during the forecast period.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40529

Increasing incidences of pneumothorax and pleural effusion to fuel market expansion

Spontaneous pneumothorax is a one of the major health problems across the globe. Spontaneous pneumothorax arises due to the air in the chest cavity which can resolve itself; however, most often requires a hospital admission and urgent medical care. The overall market for thoracic drainage devices is growing under the influence of rising awareness and increasing incidences of pneumothorax, pleural effusion, and hemothorax. Effective reimbursement policy and high awareness in developed countries is also one of the reasons responsible for the thoracic drainage devices market growth. In a military warfare setting, around 13% to 15% of penetrating wounds related to the thoracic cavity require thoracic intervention including a thoracic catheter that contributes around 30% of combat deaths. Additionally, incidence of spontaneous pneumothorax is increase gradually. Various research studies estimate that more than 2 million spontaneous pneumothorax occurs globally every year. These factors are expected to increase demand for thoracic drainage devices

Thoracic drainage system is projected to be highly lucrative product segment

A thoracic drainage system is used to collect chest drainage fluids. It is a disposable and sterile system that includes a partition system with a one-way valve, with multiple or one chambers, to remove fluid or air and avoid return of the fluid or air back into the patient. Increasing adoption of thoracic drainage systems in hospital settings owing to increased demand in surgical procedures along with advanced technological benefits such as more portability and new generation of smaller user-friendly digital systems and additional safety features.

Request Report For Discount: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40529

Thoracic surgery & pulmonology application of thoracic drainage devices market leads the market

Thoracic and pulmonological disorders are quite common and increasing. Thoracic drainage devices are used in the treatment of pneumothorax, pleural effusions, and empyema disorders.

The health care market is likely to witness more transactions and consolidations in the next three to four years. One of the major factors driving the market is constantly rising insured population base. Expanding health insurance coverage is expected to increase demand for thoracic drainage device procedures. Patients with private coverage are more likely to seek medical treatment at an urgent care center or hospital settings. According to a survey conducted by the Urgent Care Association of America (UCAOA), about 51% of urgent care revenue is currently reimbursed by private insurance and 14% by Medicare. According to industry experts, favorable insurance coverage would influence the thoracic drainage devices market significantly by penetrating the sub-urban areas. These factors are expected to boost the growth of the thoracic drainage devices market.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=40529

Ambulance Services and Urgent Care Segments Are Estimated to Witness Highest CAGR during the Forecast Period

The urgent care industry would continue to be a hotbed of deals in the next five years, as various strategic and financial partners compete to create strong geographical presence along with increase in market share. Several private equity firms have already put capital to work in UCCs across the developed country to exploit the high profit margin health care market. The market has already seen capital investment of around US$ 3.2 Bn from leading equity firms in the past few years. Hence, around 40% of the clinics surveyed by the UCAOA are expected to expand their facilities or open new clinics in 2017. Major factors that would drive the market during the forecast period are increasing penetration of ambulance services, presence of effective reimbursement policies, and rise in the geriatric population across the world. In addition, increasing number of accidents and rising incidence of heart diseases would also boost the market during the forecast period.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

[healthy-insights]

Endoscopic Balloon Dilators Market Growth, Trends and Forecast up to 2025

Endoscopy is a minimally invasive procedure with wide usage in diagnostic and therapeutic areas for pulmonology and gastroenterology conditions. Stenosis of the gastrointestinal and airway tracts is a common phenomenon caused by various reasons such as growth of benign tissue, pressure exerted by peripheral organs, symptomatic stenosis of other associated diseases such as Crohn’s disease, and inflammation and abnormal contraction of lumen muscles. Prior to evolution of endoscopic dilation techniques, physicians and surgeons used to opt for surgical interventions to dilate the stricture. Endoscopic dilation is performed by using tools such as plastic dilators, stents, dilating catheters, and balloon dilators. Plastic dilators, also known as Bougie dilators, are more rigid and traumatic. This may cause perforation of the gut wall. Temporary stenting of the stricture tract is also preferred by all surgeons. However, it is an expensive process and it requires repetition of endoscopy to remove the stent in case of benign stricture. With controlled expansion of the balloon, balloon dilators offer ease of use and safety.

Endoscopic balloon dilators are offered as single-use medical devices. The balloon dilation procedure is performed under endoscopic and fluoroscopic image guidance. The balloon is inflated with water, saline, or other liquid materials. Contrast medium is sometimes used to monitor the placement of the balloon and dilation procedure under fluoroscopic (X-Ray) image. Technological advancements in endoscopy balloon dilators have led to availability of balloon dilators of different designs, sizes, lengths, and uses. According to various independent studies, the rate of incidence of achalasia is found to be doubled from 0.8/100000 per year in the 1980s to 1.6/100000 per year post 2000. Changing dietary habits and increasing incidence of chronic diseases are likely to drive The Endoscopic Balloon Dilators Market in the near future. However, factors such as short-term dilation and requirement for repetitive procedures are likely to restrict the endoscopic balloon dilators market during the forecast period. Moreover, development of alternative, endoscopic, interventional procedures such as Per Oral Endoscopic Myotomy (POEM) and biodegradable stents is anticipated to hamper the market in the next few years.

 Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37202

 The global endoscopic balloon dilators market can be segmented based on application, end-user, and region. In terms of application, the market has been divided into pulmonology and gastrointestinal. The gastrointestinal endoscopic balloon dilators segment has been sub-classified into gastroesophageal dilators, pancreatic–biliary dilators, and achalasia dilators. Increasing prevalence of various gastrointestinal stenosis conditions is estimated to result in leading share held by the gastrointestinal segment. Based on end-user, the endoscopic balloon dilators market has been segmented into hospitals, ambulatory surgical centers, and others. Increasing adoption of minimally invasive procedures such as endoscopy in ambulatory surgical centers is estimated to propel the global endoscopic balloon dilators market from 2017 to 2025.

Geographically, the global endoscopic balloon dilators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold a leading share of the global market during the forecast period, due to high adoption of endoscopic techniques and high health care expenditure in the region. Europe is estimated to account for a significant share of the global market for endoscopic balloon dilators during the forecast period. Increasing awareness about gastrointestinal and pulmonary stenosis and developing health care infrastructure in emerging markets such as China and India are projected to be responsible for significant growth of the endoscopic balloon dilators market in Asia Pacific during the forecast period.

Major players operating in the global endoscopic balloon dilators market are Boston Scientific Corporation, Olympus Medical Corporation, Merit Medical Endotek, Cook Medical, CONMED Corporation, HOBBS MEDICAL INC., Medi-Globe GmbH, and PanMed US.

 Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=37202&ltype=S

 About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

[forwardhealth-blog]

New Post has been published on The best traditions of medicine for the whole family!

New Post has been published on http://bit.ly/2y2TL7K

Interventional Pulmonology Market Size will Observe Lucrative Surge by the End 2024 bronchoscopy complications